Oral Session

Oral Session 1-7A DLBCL: Prognosis and pathology (1)

Fri. Oct 12, 2018 9:00 AM - 10:00 AM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Hirokazu Nagai (National Hospital Organization Nagoya Medical Center Depertment of Hematology/ Oncology Research, Japan)

+Add all to schedule

[OS1-7A-1] Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma (prDLBCL)

Tomotaka Suzuki¹, Dai Maruyama¹, Akiko Miyagi Maeshima², Junko Nomoto¹, Kinuko Tajima¹, Yuta Ito¹, Shunsuke Hatta¹, Sayako Yuda¹, Shinichi Makita¹, Suguru Fukuhara¹, Wataru Munakata¹, Tatsuya Suzuki¹, Hirokazu Taniguchi², Koji Izutsu¹, Yukio Kobayashi¹, Kensei Tobinai¹ (1.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, 2.Department of Pathology, National Cancer Center Hospital, Tokyo, Japan)

[OS1-7A-2] Safety and efficacy of R-CHOP and R-THP-COP for diffuse large B cell lymphoma in our institute

Keisuke Tanaka, Makiko Sekiguchi, Mai Kuboki, Atsushi Hamamura, Norihiko Nakamura, Shigeo Toyota (Hematol, Yokosuka Kyosai Hospital, Kanagawa, Japan)

[OS1-7A-3] A clinicopathological study of 23 cases of IVL: Proposal for an optimal method of random skin biopsy

Akihiro Kitadate¹, Naoko Enzan², Hiroki Kobayashi¹, Yoshiaki Abe¹, Kentaro Narita¹, Masami Takeuchi¹, Atsushi Tanaka², Kosei Matsue¹ (1.Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan, 2.Department of Dermatology, Kameda Medical Center, Kamogawa, Japan)

[OS1-7A-4] Prognostic impact of interim serum soluble interleukin-2 receptor levels in DLBCL

Haruya Okamoto¹, Naoko Tatsumi¹, Yukiko Komori¹, Nana Sasaki¹, Yasuhiko Tsutsumi¹, Eri Kawata¹, Teruaki Akaogi¹, Yutaka Kobayashi¹, Nobuhiko Uoshima¹ (1.Hematol,Japanese Red Cross Kyoto Daini Hospital , Kyoto,Japan, 2.Japanese Red Cross Kyoto Daini Hospital , Kyoto,Japan)

[OS1-7A-5] Clinical significance of tryptophan catabolism in newly diagnosed diffuse large B-cell lymphoma

Ayako Masaki^1,2, Shigeru Kusumoto¹, Yasuhiro Maeda³, Tomoko Narita¹, Asahi Ito¹, Shiori Kinoshita¹, Takashi Yoshida¹, Masaki Ri¹, Hirokazu Komatsu¹, Takashi Ishida⁴, Hiroshi Inagaki², Ryuzo Ueda⁵, Shinsuke Iida¹ (1.Hematology and Oncology, Nagoya City Univ, Nagoya, Japan, 2.Pathology and Molecular Diagnostics, Nagoya City Univ, Nagoya, Japan, 3.Laboratory of Hospital Pharmacy, Nagoya City Univ, Nagoya, Japan, 4.Hematology and Oncology, Internal Medicine, Iwate Medical Univ, Morioka, Japan, 5.Tumor Immunology, Aichi Medical Univ, Nagakute, Japan)

[OS1-7A-6] Clinical significance of bone marrow biopsy for diffuse large B-cell lymphoma: A retrospective study

Yoshiaki Marumo¹, Shigeru Kusumoto¹, Ayako Masaki², Yoshiko Ohshima¹, Haruna Fujinami¹, Takuto Tachita¹, Hirokazu Sasaki¹, Takashi Yoshida¹, Tomoko Narita¹, Asahi Ito¹, Masaki Ri¹, Hirokazu Komatsu¹, Hiroshi Inagaki², Shinsuke Iida¹ (1.Hematology and Oncology, Nagoya City University, Nagoya, Japan, 2.Pathology and Molecular Diagnostics, Nagoya City University, Nagoya, Japan)